Latest Underwriting Agreements News

Red Sky Energy is set to raise up to $5.2 million through a placement and rights issue to fund its participation in a Santos-operated drilling program in South Australia’s Innamincka Dome. The capital raise aims to accelerate near-term production and cash flow from existing and new wells.

Estrella Resources has inked an $8 million underwriting agreement with Million Link (China) Investment Ltd to support the exercise of 445 million listed options, aiming to strengthen its capital position ahead of the options’ December expiry.

Identitii Limited has closed its recent rights issue, raising $379,336 before costs but falling short by $2.5 million after the termination of its underwriting agreement. The company plans to issue new shares and place the remaining shortfall to fund growth initiatives for its BNDRY platform.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.

Identitii Limited faces a setback as Beauvais Capital terminates its underwriting agreement following Takeovers Panel orders, triggering shareholder withdrawal rights and uncertainty over the company’s capital raising plans.

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

The Takeovers Panel has declared unacceptable circumstances in Identitii Limited's recent rights issue, ordering supplementary disclosure and a reopening of the offer to protect shareholder interests and market integrity.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

Estrella Resources has entered a $2 million underwriting agreement to support the exercise of its listed options, ensuring capital inflow ahead of the December expiry.